OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
Zhaolin Chen, Ying Hu, Le Jin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14

Showing 14 citing articles:

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8

RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis
Yi Li, Ning-Xi Wang, Chuan Yin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9656-9656
Open Access | Times Cited: 27

A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics
Mahdi Asghari Ozma, Seyyed Reza Moaddab, Hedayat Hosseini, et al.
Critical Reviews in Food Science and Nutrition (2023), pp. 1-19
Closed Access | Times Cited: 18

Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access

The Epitranscriptomic Mechanism of Metal Toxicity and Carcinogenesis
Chengfeng Yang, Zhishan Wang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11830-11830
Open Access | Times Cited: 23

Unraveling the cross‐talk between N6‐methyladenosine modification and non‐coding RNAs in breast cancer: Mechanisms and clinical implications
Xuan Liu, Xuelong Xie, Chentao Sui, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 11, pp. 1877-1889
Closed Access | Times Cited: 3

PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt–β-catenin pathway
Peng Yu, Tutu Xu, Wenmeng Ma, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3

MeCP2 and transcriptional control of eukaryotic gene expression
Ghanan Bin Akhtar, Marjorie Buist, Mojgan Rastegar
European Journal of Cell Biology (2022) Vol. 101, Iss. 3, pp. 151237-151237
Open Access | Times Cited: 12

Global DNA Methylation Levels in Epstein-Barr-Virus-Positive Iraqi Patients with Acute Lymphoblastic Leukaemia
Fadhel M. Lafta, Rakad M. Kh. Al-Jumaily, Lubna Muhi Rasoul
Iraqi Journal of Science (2023), pp. 1109-1118
Open Access | Times Cited: 5

Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposure
Kellianne M. Piell, Belinda J. Petri, Kimberly Z. Head, et al.
Environmental Toxicology and Pharmacology (2023) Vol. 100, pp. 104138-104138
Open Access | Times Cited: 4

Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment
Ke Zhang, Junyao Wang, Ziyan He, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 559-559
Open Access | Times Cited: 3

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma
Bing-fan Xie, Yan Xia, Dan-huan Lin, et al.
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 3

The role of N6-methyladenosine RNA modification in platinum resistance
Kai Wang, Lingfang Wang, Xiaojing Chen, et al.
Epigenomics (2023) Vol. 15, Iss. 22, pp. 1221-1232
Closed Access

Page 1

Scroll to top